Trial Profile
A Double-blind Study of the Pharmacokinetic and Pharmacodynamic Properties of BIOD-123 and BIOD-125 Compared to Humalog in Subjects With Type 1 Diabetes Including Assessments of Safety and Injection Site Toleration
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Insulin (Primary) ; Insulin lispro
- Indications Type 1 diabetes mellitus
- Focus Pharmacokinetics
- 01 Aug 2013 New trial record